|
000
| 00993nam##2200229za#4500 |
|---|
| 001 | 9.575437 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210624184650 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150406|2002||||xxc|||||o f|0| 0 eng|d |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH81-3/2002-17E-PDF |
|---|
| 110 | 1 |aCanada. |bPatented Medicine Prices Review Board. |
|---|
| 245 | 12|aA comparison of pharmaceutical research and development spending |h[electronic resource] |
|---|
| 260 | |aOttawa - Ontario : |bPatented Medicine Prices Review Board |cDecember 2002. |
|---|
| 300 | |a30p.|bfigs., tables |
|---|
| 490 | 1 |aPMPRB study series |vS-0217 |
|---|
| 590 | |a12-42-Supp|b2012-11-21 |
|---|
| 775 | 08|tAnalyse comparative des dépenses en recherche et développement dans l'industrie pharmaceutique |w(CaOODSP)9.604964 |
|---|
| 830 | #0|aPMPRB study series ;|vS-0217|w(CaOODSP)9.507338 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s446 KB|uhttps://publications.gc.ca/collections/collection_2012/cepmb-pmprb/H81-3-2002-17-eng.pdf|yS-0217 |
|---|